[
  {
    "title": "Drug Stocks Are the New Safe Bet in a Shaky Market",
    "published": 1740726000,
    "day_prices": {
      "2025-02-28T14:30:00+00:00": 58.970001220703125,
      "2025-02-28T15:30:00+00:00": 58.44499969482422,
      "2025-02-28T16:30:00+00:00": 58.584999084472656,
      "2025-02-28T17:30:00+00:00": 58.61000061035156,
      "2025-02-28T18:30:00+00:00": 58.619998931884766,
      "2025-02-28T19:30:00+00:00": 58.95000076293945,
      "2025-02-28T20:30:00+00:00": 59.04999923706055
    },
    "sentiment": 0.39812377095222473
  },
  {
    "title": "Bristol Myers Squibb Co. stock outperforms competitors despite losses on the day",
    "published": 1740587820,
    "day_prices": {
      "2025-02-26T14:30:00+00:00": 58.15999984741211,
      "2025-02-26T15:30:00+00:00": 58.11000061035156,
      "2025-02-26T16:30:00+00:00": 57.76499938964844,
      "2025-02-26T17:30:00+00:00": 57.71500015258789,
      "2025-02-26T18:30:00+00:00": 57.334999084472656,
      "2025-02-26T19:30:00+00:00": 57.415000915527344,
      "2025-02-26T20:30:00+00:00": 57.36000061035156
    },
    "sentiment": 0.9329361319541931
  },
  {
    "title": "Merck's Oncology Strength: Beating Wall Street Again",
    "published": 1740561344,
    "day_prices": {
      "2025-02-26T14:30:00+00:00": 58.15999984741211,
      "2025-02-26T15:30:00+00:00": 58.11000061035156,
      "2025-02-26T16:30:00+00:00": 57.76499938964844,
      "2025-02-26T17:30:00+00:00": 57.71500015258789,
      "2025-02-26T18:30:00+00:00": 57.334999084472656,
      "2025-02-26T19:30:00+00:00": 57.415000915527344,
      "2025-02-26T20:30:00+00:00": 57.36000061035156
    },
    "sentiment": 0.8620699644088745
  },
  {
    "title": "Hims & Hers Stumbles as GLP-1 Compounding Ends. Lilly Presses the Advantage.",
    "published": 1740477240,
    "day_prices": {
      "2025-02-25T14:30:00+00:00": 58.29999923706055,
      "2025-02-25T15:30:00+00:00": 59.540000915527344,
      "2025-02-25T16:30:00+00:00": 59.080101013183594,
      "2025-02-25T17:30:00+00:00": 58.81999969482422,
      "2025-02-25T18:30:00+00:00": 58.720001220703125,
      "2025-02-25T19:30:00+00:00": 58.47159957885742,
      "2025-02-25T20:30:00+00:00": 58.3650016784668
    },
    "sentiment": 0.8708897829055786
  },
  {
    "title": "Bristol Myers Gets Speedy FDA Review of Opdivo/Yervoy Combo in Certain Colorectal Cancer Patients",
    "published": 1740382572,
    "day_prices": {
      "2025-02-24T14:30:00+00:00": 55.970001220703125,
      "2025-02-24T15:30:00+00:00": 57.58000183105469,
      "2025-02-24T16:30:00+00:00": 57.380001068115234,
      "2025-02-24T17:30:00+00:00": 57.69499969482422,
      "2025-02-24T18:30:00+00:00": 57.474998474121094,
      "2025-02-24T19:30:00+00:00": 57.709999084472656,
      "2025-02-24T20:30:00+00:00": 57.665000915527344
    },
    "sentiment": 0.7358264327049255
  },
  {
    "title": "U.S. Food and Drug Administration Accepts Bristol Myers Squibb\u2019s Supplemental Biologics License Application for Opdivo\u00ae Plus Yervoy\u00ae for Patients with Unresectable or Metastatic Microsatellite Instability-High or Mismatch Repair Deficient...",
    "published": 1740380404,
    "day_prices": {
      "2025-02-24T14:30:00+00:00": 55.970001220703125,
      "2025-02-24T15:30:00+00:00": 57.58000183105469,
      "2025-02-24T16:30:00+00:00": 57.380001068115234,
      "2025-02-24T17:30:00+00:00": 57.69499969482422,
      "2025-02-24T18:30:00+00:00": 57.474998474121094,
      "2025-02-24T19:30:00+00:00": 57.709999084472656,
      "2025-02-24T20:30:00+00:00": 57.665000915527344
    },
    "sentiment": 0.9070932865142822
  },
  {
    "title": "Why AbbVie Remains A Strong Buy For Long-Term Investors",
    "published": 1740311542,
    "day_prices": {},
    "sentiment": 0.5346829891204834
  },
  {
    "title": "Bristol Myers Squibb Announces Opdivo Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer",
    "published": 1740045439,
    "day_prices": {
      "2025-02-20T14:30:00+00:00": 55.02000045776367,
      "2025-02-20T15:30:00+00:00": 55.3849983215332,
      "2025-02-20T16:30:00+00:00": 55.59000015258789,
      "2025-02-20T17:30:00+00:00": 55.166500091552734,
      "2025-02-20T18:30:00+00:00": 54.98500061035156,
      "2025-02-20T19:30:00+00:00": 55.15999984741211,
      "2025-02-20T20:30:00+00:00": 55.38999938964844
    },
    "sentiment": 0.8969193696975708
  },
  {
    "title": "Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors despite daily gains",
    "published": 1739983140,
    "day_prices": {
      "2025-02-19T14:30:00+00:00": 54.40999984741211,
      "2025-02-19T15:30:00+00:00": 54.459999084472656,
      "2025-02-19T16:30:00+00:00": 54.36000061035156,
      "2025-02-19T17:30:00+00:00": 54.279998779296875,
      "2025-02-19T18:30:00+00:00": 54.71900177001953,
      "2025-02-19T19:30:00+00:00": 54.85499954223633,
      "2025-02-19T20:30:00+00:00": 54.85499954223633
    },
    "sentiment": 0.8358743190765381
  },
  {
    "title": "Push UPs [Stocks] Vs Pull DOWNs [Retail Sales]",
    "published": 1739897952,
    "day_prices": {
      "2025-02-18T14:30:00+00:00": 53.720001220703125,
      "2025-02-18T15:30:00+00:00": 54.20000076293945,
      "2025-02-18T16:30:00+00:00": 54.15999984741211,
      "2025-02-18T17:30:00+00:00": 54.34000015258789,
      "2025-02-18T18:30:00+00:00": 54.35710144042969,
      "2025-02-18T19:30:00+00:00": 54.32500076293945,
      "2025-02-18T20:30:00+00:00": 54.47990036010742
    },
    "sentiment": 0.615708589553833
  },
  {
    "title": "GSK's Strong Performance: Why I'm Upgrading To 'Strong Buy'",
    "published": 1739845293,
    "day_prices": {
      "2025-02-18T14:30:00+00:00": 53.720001220703125,
      "2025-02-18T15:30:00+00:00": 54.20000076293945,
      "2025-02-18T16:30:00+00:00": 54.15999984741211,
      "2025-02-18T17:30:00+00:00": 54.34000015258789,
      "2025-02-18T18:30:00+00:00": 54.35710144042969,
      "2025-02-18T19:30:00+00:00": 54.32500076293945,
      "2025-02-18T20:30:00+00:00": 54.47990036010742
    },
    "sentiment": 0.7906397581100464
  },
  {
    "title": "Buy 5 'Safer' Dividend Dogs Of 23 February Barron's Better Bets Than T-Bills",
    "published": 1739692419,
    "day_prices": {},
    "sentiment": 0.6217218637466431
  },
  {
    "title": "Janus Henderson Global Equity Income Fund Q4 2024 Commentary",
    "published": 1739478840,
    "day_prices": {
      "2025-02-13T14:30:00+00:00": 56.25,
      "2025-02-13T15:30:00+00:00": 55.744998931884766,
      "2025-02-13T16:30:00+00:00": 55.939998626708984,
      "2025-02-13T17:30:00+00:00": 55.994998931884766,
      "2025-02-13T18:30:00+00:00": 56.095001220703125,
      "2025-02-13T19:30:00+00:00": 56.17499923706055,
      "2025-02-13T20:30:00+00:00": 55.88999938964844
    },
    "sentiment": 0.9426544308662415
  },
  {
    "title": "Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors",
    "published": 1739205420,
    "day_prices": {
      "2025-02-10T14:30:00+00:00": 56.79999923706055,
      "2025-02-10T15:30:00+00:00": 54.744998931884766,
      "2025-02-10T16:30:00+00:00": 55.630001068115234,
      "2025-02-10T17:30:00+00:00": 55.314998626708984,
      "2025-02-10T18:30:00+00:00": 55.51499938964844,
      "2025-02-10T19:30:00+00:00": 55.470001220703125,
      "2025-02-10T20:30:00+00:00": 55.44499969482422
    },
    "sentiment": 0.9435314536094666
  },
  {
    "title": "Bristol Myers Squibb Sees Positive Results for Breyanzi in Lymphoma Trials",
    "published": 1739174640,
    "day_prices": {
      "2025-02-10T14:30:00+00:00": 56.79999923706055,
      "2025-02-10T15:30:00+00:00": 54.744998931884766,
      "2025-02-10T16:30:00+00:00": 55.630001068115234,
      "2025-02-10T17:30:00+00:00": 55.314998626708984,
      "2025-02-10T18:30:00+00:00": 55.51499938964844,
      "2025-02-10T19:30:00+00:00": 55.470001220703125,
      "2025-02-10T20:30:00+00:00": 55.44499969482422
    },
    "sentiment": 0.9524204730987549
  },
  {
    "title": "Bristol-Myers Squibb: Solid Q4 Earnings, But Weak Guidance And Patent Concerns Drive The Stock Down",
    "published": 1738933208,
    "day_prices": {
      "2025-02-07T14:30:00+00:00": 57.459999084472656,
      "2025-02-07T15:30:00+00:00": 56.68000030517578,
      "2025-02-07T16:30:00+00:00": 56.66999816894531,
      "2025-02-07T17:30:00+00:00": 56.47999954223633,
      "2025-02-07T18:30:00+00:00": 56.494998931884766,
      "2025-02-07T19:30:00+00:00": 56.57500076293945,
      "2025-02-07T20:30:00+00:00": 56.314998626708984
    },
    "sentiment": 0.9706059098243713
  },
  {
    "title": "Health Care Climbs After Lilly Earnings - Health Care Roundup",
    "published": 1738862460,
    "day_prices": {
      "2025-02-06T14:30:00+00:00": 57.369998931884766,
      "2025-02-06T15:30:00+00:00": 58.69499969482422,
      "2025-02-06T16:30:00+00:00": 58.7599983215332,
      "2025-02-06T17:30:00+00:00": 58.525001525878906,
      "2025-02-06T18:30:00+00:00": 58.099998474121094,
      "2025-02-06T19:30:00+00:00": 57.43000030517578,
      "2025-02-06T20:30:00+00:00": 57.095001220703125
    },
    "sentiment": 0.5447070002555847
  },
  {
    "title": "Bristol-Myers Squibb Company (BMY) Q4 2024 Earnings Conference Call Transcript",
    "published": 1738849277,
    "day_prices": {
      "2025-02-06T14:30:00+00:00": 57.369998931884766,
      "2025-02-06T15:30:00+00:00": 58.69499969482422,
      "2025-02-06T16:30:00+00:00": 58.7599983215332,
      "2025-02-06T17:30:00+00:00": 58.525001525878906,
      "2025-02-06T18:30:00+00:00": 58.099998474121094,
      "2025-02-06T19:30:00+00:00": 57.43000030517578,
      "2025-02-06T20:30:00+00:00": 57.095001220703125
    },
    "sentiment": 0.9301918745040894
  },
  {
    "title": "Bristol Myers Earnings Are a \u2018Tale of 2 Trends\u2019 as Guidance Falls Short. The Stock Is Falling",
    "published": 1738830300,
    "day_prices": {
      "2025-02-06T14:30:00+00:00": 57.369998931884766,
      "2025-02-06T15:30:00+00:00": 58.69499969482422,
      "2025-02-06T16:30:00+00:00": 58.7599983215332,
      "2025-02-06T17:30:00+00:00": 58.525001525878906,
      "2025-02-06T18:30:00+00:00": 58.099998474121094,
      "2025-02-06T19:30:00+00:00": 57.43000030517578,
      "2025-02-06T20:30:00+00:00": 57.095001220703125
    },
    "sentiment": 0.7980320453643799
  },
  {
    "title": "Bristol Myers Squibb's 4Q Beats Forecasts; Generics Dent 2025 Outlook",
    "published": 1738825140,
    "day_prices": {
      "2025-02-06T14:30:00+00:00": 57.369998931884766,
      "2025-02-06T15:30:00+00:00": 58.69499969482422,
      "2025-02-06T16:30:00+00:00": 58.7599983215332,
      "2025-02-06T17:30:00+00:00": 58.525001525878906,
      "2025-02-06T18:30:00+00:00": 58.099998474121094,
      "2025-02-06T19:30:00+00:00": 57.43000030517578,
      "2025-02-06T20:30:00+00:00": 57.095001220703125
    },
    "sentiment": 0.9201095104217529
  },
  {
    "title": "Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma",
    "published": 1738573456,
    "day_prices": {
      "2025-02-03T14:30:00+00:00": 58.790000915527344,
      "2025-02-03T15:30:00+00:00": 59.83000183105469,
      "2025-02-03T16:30:00+00:00": 60.0984992980957,
      "2025-02-03T17:30:00+00:00": 60.209999084472656,
      "2025-02-03T18:30:00+00:00": 59.974998474121094,
      "2025-02-03T19:30:00+00:00": 59.67499923706055,
      "2025-02-03T20:30:00+00:00": 59.79999923706055
    },
    "sentiment": 0.9353787899017334
  },
  {
    "title": "ORIC Pharmaceuticals: Too Early To Commit, Despite Some Good Early Data",
    "published": 1738472729,
    "day_prices": {},
    "sentiment": 0.5866532325744629
  },
  {
    "title": "No One Knows How to Price AI Tools",
    "published": 1738396800,
    "day_prices": {},
    "sentiment": 0.9424499869346619
  },
  {
    "title": "Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors",
    "published": 1743310800,
    "day_prices": {},
    "sentiment": 0.735475480556488
  },
  {
    "title": "Jim Cramer on Bristol-Myers Squibb. Co (NYSE:BMY): They Should Have Known Better",
    "published": 1743255487,
    "day_prices": {},
    "sentiment": 0.8838437795639038
  },
  {
    "title": "Dividend Champion, Contender, And Challenger Highlights: Week Of March 30",
    "published": 1743213342,
    "day_prices": {},
    "sentiment": 0.9083054661750793
  },
  {
    "title": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
    "published": 1743179820,
    "day_prices": {
      "2025-03-28T13:30:00+00:00": 59.400001525878906,
      "2025-03-28T14:30:00+00:00": 58.904998779296875,
      "2025-03-28T15:30:00+00:00": 59.060001373291016,
      "2025-03-28T16:30:00+00:00": 59.099998474121094,
      "2025-03-28T17:30:00+00:00": 59.3650016784668,
      "2025-03-28T18:30:00+00:00": 59.34000015258789,
      "2025-03-28T19:30:00+00:00": 59.744998931884766
    },
    "sentiment": 0.9373340010643005
  },
  {
    "title": "Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo\u00ae (nivolumab) Across Multiple Solid Tumor Indications",
    "published": 1743163200,
    "day_prices": {
      "2025-03-28T13:30:00+00:00": 59.400001525878906,
      "2025-03-28T14:30:00+00:00": 58.904998779296875,
      "2025-03-28T15:30:00+00:00": 59.060001373291016,
      "2025-03-28T16:30:00+00:00": 59.099998474121094,
      "2025-03-28T17:30:00+00:00": 59.3650016784668,
      "2025-03-28T18:30:00+00:00": 59.34000015258789,
      "2025-03-28T19:30:00+00:00": 59.744998931884766
    },
    "sentiment": 0.9492398500442505
  },
  {
    "title": "Bristol Myers Gets CHMP Backing for Subcutaneous Opdivo",
    "published": 1743151808,
    "day_prices": {
      "2025-03-28T13:30:00+00:00": 59.400001525878906,
      "2025-03-28T14:30:00+00:00": 58.904998779296875,
      "2025-03-28T15:30:00+00:00": 59.060001373291016,
      "2025-03-28T16:30:00+00:00": 59.099998474121094,
      "2025-03-28T17:30:00+00:00": 59.3650016784668,
      "2025-03-28T18:30:00+00:00": 59.34000015258789,
      "2025-03-28T19:30:00+00:00": 59.744998931884766
    },
    "sentiment": 0.6872575283050537
  },
  {
    "title": "Arbutus Biopharma (ABUS) Reports Q4 Loss, Tops Revenue Estimates",
    "published": 1743079502,
    "day_prices": {
      "2025-03-27T13:30:00+00:00": 59.18000030517578,
      "2025-03-27T14:30:00+00:00": 59.084999084472656,
      "2025-03-27T15:30:00+00:00": 59.224998474121094,
      "2025-03-27T16:30:00+00:00": 59.089900970458984,
      "2025-03-27T17:30:00+00:00": 58.91999816894531,
      "2025-03-27T18:30:00+00:00": 59.119998931884766,
      "2025-03-27T19:30:00+00:00": 58.95000076293945
    },
    "sentiment": 0.9732887148857117
  },
  {
    "title": "Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.",
    "published": 1743070920,
    "day_prices": {
      "2025-03-27T13:30:00+00:00": 59.18000030517578,
      "2025-03-27T14:30:00+00:00": 59.084999084472656,
      "2025-03-27T15:30:00+00:00": 59.224998474121094,
      "2025-03-27T16:30:00+00:00": 59.089900970458984,
      "2025-03-27T17:30:00+00:00": 58.91999816894531,
      "2025-03-27T18:30:00+00:00": 59.119998931884766,
      "2025-03-27T19:30:00+00:00": 58.95000076293945
    },
    "sentiment": 0.9064256548881531
  },
  {
    "title": "Jim Cramer on Merck (MRK): \u201cI Like It at This Level \u2013 But I Like Bristol-Myers Even More!\u201d",
    "published": 1743011113,
    "day_prices": {
      "2025-03-26T13:30:00+00:00": 59.31999969482422,
      "2025-03-26T14:30:00+00:00": 59.43000030517578,
      "2025-03-26T15:30:00+00:00": 59.060001373291016,
      "2025-03-26T16:30:00+00:00": 59.04999923706055,
      "2025-03-26T17:30:00+00:00": 59.064998626708984,
      "2025-03-26T18:30:00+00:00": 59.06999969482422,
      "2025-03-26T19:30:00+00:00": 59.05500030517578
    },
    "sentiment": 0.7015296816825867
  },
  {
    "title": "1 Large-Cap Stock on Our Watchlist and 2 to Brush Off",
    "published": 1742994108,
    "day_prices": {
      "2025-03-26T13:30:00+00:00": 59.31999969482422,
      "2025-03-26T14:30:00+00:00": 59.43000030517578,
      "2025-03-26T15:30:00+00:00": 59.060001373291016,
      "2025-03-26T16:30:00+00:00": 59.04999923706055,
      "2025-03-26T17:30:00+00:00": 59.064998626708984,
      "2025-03-26T18:30:00+00:00": 59.06999969482422,
      "2025-03-26T19:30:00+00:00": 59.05500030517578
    },
    "sentiment": 0.7775726914405823
  },
  {
    "title": "Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors",
    "published": 1742920200,
    "day_prices": {
      "2025-03-25T13:30:00+00:00": 61.209999084472656,
      "2025-03-25T14:30:00+00:00": 61.20000076293945,
      "2025-03-25T15:30:00+00:00": 61.064998626708984,
      "2025-03-25T16:30:00+00:00": 61.11000061035156,
      "2025-03-25T17:30:00+00:00": 60.540000915527344,
      "2025-03-25T18:30:00+00:00": 59.9275016784668,
      "2025-03-25T19:30:00+00:00": 59.220001220703125
    },
    "sentiment": 0.9303045272827148
  },
  {
    "title": "Bristol-Myers Squibb's Rally Is Well Deserved, Albeit Warranting A Downgrade To Hold",
    "published": 1742898153,
    "day_prices": {
      "2025-03-25T13:30:00+00:00": 61.209999084472656,
      "2025-03-25T14:30:00+00:00": 61.20000076293945,
      "2025-03-25T15:30:00+00:00": 61.064998626708984,
      "2025-03-25T16:30:00+00:00": 61.11000061035156,
      "2025-03-25T17:30:00+00:00": 60.540000915527344,
      "2025-03-25T18:30:00+00:00": 59.9275016784668,
      "2025-03-25T19:30:00+00:00": 59.220001220703125
    },
    "sentiment": 0.7988899350166321
  },
  {
    "title": "Is Bristol-Myers Squibb (BMY) The Best Healthcare Dividend Stock to Invest in?",
    "published": 1742821749,
    "day_prices": {
      "2025-03-24T13:30:00+00:00": 60.790000915527344,
      "2025-03-24T14:30:00+00:00": 60.380001068115234,
      "2025-03-24T15:30:00+00:00": 60.81999969482422,
      "2025-03-24T16:30:00+00:00": 60.82500076293945,
      "2025-03-24T17:30:00+00:00": 60.79999923706055,
      "2025-03-24T18:30:00+00:00": 61.005001068115234,
      "2025-03-24T19:30:00+00:00": 61.025001525878906
    },
    "sentiment": 0.8218977451324463
  },
  {
    "title": "8 key drug patents expiring soon \u2014 and what it means for the market",
    "published": 1742806800,
    "day_prices": {
      "2025-03-24T13:30:00+00:00": 60.790000915527344,
      "2025-03-24T14:30:00+00:00": 60.380001068115234,
      "2025-03-24T15:30:00+00:00": 60.81999969482422,
      "2025-03-24T16:30:00+00:00": 60.82500076293945,
      "2025-03-24T17:30:00+00:00": 60.79999923706055,
      "2025-03-24T18:30:00+00:00": 61.005001068115234,
      "2025-03-24T19:30:00+00:00": 61.025001525878906
    },
    "sentiment": 0.8885151147842407
  },
  {
    "title": "Bristol-Myers Squibb Company (BMY): Among Incredibly Cheap Dividend Stock to Buy Now",
    "published": 1742577940,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 60.22999954223633,
      "2025-03-21T14:30:00+00:00": 60.59000015258789,
      "2025-03-21T15:30:00+00:00": 61.05500030517578,
      "2025-03-21T16:30:00+00:00": 61.20500183105469,
      "2025-03-21T17:30:00+00:00": 61.060001373291016,
      "2025-03-21T18:30:00+00:00": 60.79999923706055,
      "2025-03-21T19:30:00+00:00": 60.595001220703125
    },
    "sentiment": 0.5305382609367371
  },
  {
    "title": "Merck Vs. Bristol-Myers Squibb: Which Pharma Stock Should You Buy",
    "published": 1742541707,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 60.22999954223633,
      "2025-03-21T14:30:00+00:00": 60.59000015258789,
      "2025-03-21T15:30:00+00:00": 61.05500030517578,
      "2025-03-21T16:30:00+00:00": 61.20500183105469,
      "2025-03-21T17:30:00+00:00": 61.060001373291016,
      "2025-03-21T18:30:00+00:00": 60.79999923706055,
      "2025-03-21T19:30:00+00:00": 60.595001220703125
    },
    "sentiment": 0.9369224905967712
  },
  {
    "title": "2 High-Yield Dividend Stocks That Are Bargain Buys Right Now",
    "published": 1742475600,
    "day_prices": {
      "2025-03-20T13:30:00+00:00": 59.86000061035156,
      "2025-03-20T14:30:00+00:00": 60.80500030517578,
      "2025-03-20T15:30:00+00:00": 60.0099983215332,
      "2025-03-20T16:30:00+00:00": 59.866798400878906,
      "2025-03-20T17:30:00+00:00": 59.91999816894531,
      "2025-03-20T18:30:00+00:00": 59.98189926147461,
      "2025-03-20T19:30:00+00:00": 60.209999084472656
    },
    "sentiment": 0.9253113269805908
  },
  {
    "title": "Is Bristol-Myers Squibb (BMY) the Most Undervalued Biotech Stock to Invest In?",
    "published": 1742394833,
    "day_prices": {
      "2025-03-19T13:30:00+00:00": 59.86000061035156,
      "2025-03-19T14:30:00+00:00": 60.11000061035156,
      "2025-03-19T15:30:00+00:00": 59.83000183105469,
      "2025-03-19T16:30:00+00:00": 59.915000915527344,
      "2025-03-19T17:30:00+00:00": 59.5,
      "2025-03-19T18:30:00+00:00": 59.630001068115234,
      "2025-03-19T19:30:00+00:00": 59.974998474121094
    },
    "sentiment": 0.8927408456802368
  },
  {
    "title": "10 Undervalued Dividend Growth Stocks: March 2025",
    "published": 1742374800,
    "day_prices": {
      "2025-03-19T13:30:00+00:00": 59.86000061035156,
      "2025-03-19T14:30:00+00:00": 60.11000061035156,
      "2025-03-19T15:30:00+00:00": 59.83000183105469,
      "2025-03-19T16:30:00+00:00": 59.915000915527344,
      "2025-03-19T17:30:00+00:00": 59.5,
      "2025-03-19T18:30:00+00:00": 59.630001068115234,
      "2025-03-19T19:30:00+00:00": 59.974998474121094
    },
    "sentiment": 0.8844249844551086
  },
  {
    "title": "Bristol-Myers Squibb Company (BMY): A Bull Case Theory",
    "published": 1742232900,
    "day_prices": {
      "2025-03-17T13:30:00+00:00": 59.15999984741211,
      "2025-03-17T14:30:00+00:00": 59.40999984741211,
      "2025-03-17T15:30:00+00:00": 59.40999984741211,
      "2025-03-17T16:30:00+00:00": 59.34000015258789,
      "2025-03-17T17:30:00+00:00": 59.61000061035156,
      "2025-03-17T18:30:00+00:00": 59.79499816894531,
      "2025-03-17T19:30:00+00:00": 59.875
    },
    "sentiment": 0.9351198077201843
  },
  {
    "title": "We Could Have A Clear Shot To 6,000, But Be Proactive",
    "published": 1742156053,
    "day_prices": {},
    "sentiment": 0.6950020790100098
  },
  {
    "title": "Bristol-Myers Squibb (NYSE:BMY) Gets EC Nod For Breyanzi In NHL Treatment",
    "published": 1741973244,
    "day_prices": {
      "2025-03-14T13:30:00+00:00": 59.84000015258789,
      "2025-03-14T14:30:00+00:00": 59.415000915527344,
      "2025-03-14T15:30:00+00:00": 59.310001373291016,
      "2025-03-14T16:30:00+00:00": 59.000099182128906,
      "2025-03-14T17:30:00+00:00": 59.05500030517578,
      "2025-03-14T18:30:00+00:00": 58.81999969482422,
      "2025-03-14T19:30:00+00:00": 58.86000061035156
    },
    "sentiment": 0.7362377047538757
  },
  {
    "title": "Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma",
    "published": 1741949940,
    "day_prices": {
      "2025-03-14T13:30:00+00:00": 59.84000015258789,
      "2025-03-14T14:30:00+00:00": 59.415000915527344,
      "2025-03-14T15:30:00+00:00": 59.310001373291016,
      "2025-03-14T16:30:00+00:00": 59.000099182128906,
      "2025-03-14T17:30:00+00:00": 59.05500030517578,
      "2025-03-14T18:30:00+00:00": 58.81999969482422,
      "2025-03-14T19:30:00+00:00": 58.86000061035156
    },
    "sentiment": 0.9269002676010132
  },
  {
    "title": "Bristol Myers Gets Expanded European Approval for Breyanzi",
    "published": 1741937547,
    "day_prices": {
      "2025-03-14T13:30:00+00:00": 59.84000015258789,
      "2025-03-14T14:30:00+00:00": 59.415000915527344,
      "2025-03-14T15:30:00+00:00": 59.310001373291016,
      "2025-03-14T16:30:00+00:00": 59.000099182128906,
      "2025-03-14T17:30:00+00:00": 59.05500030517578,
      "2025-03-14T18:30:00+00:00": 58.81999969482422,
      "2025-03-14T19:30:00+00:00": 58.86000061035156
    },
    "sentiment": 0.8762357831001282
  },
  {
    "title": "Gilead (GILD) Up 10.3% Since Last Earnings Report: Can It Continue?",
    "published": 1741879829,
    "day_prices": {
      "2025-03-13T13:30:00+00:00": 59.9900016784668,
      "2025-03-13T14:30:00+00:00": 60.5,
      "2025-03-13T15:30:00+00:00": 60.630001068115234,
      "2025-03-13T16:30:00+00:00": 60.43000030517578,
      "2025-03-13T17:30:00+00:00": 60.224998474121094,
      "2025-03-13T18:30:00+00:00": 60.16999816894531,
      "2025-03-13T19:30:00+00:00": 60.23500061035156
    },
    "sentiment": 0.9539879560470581
  },
  {
    "title": "Healthcare Sector Trying To Bounce Back",
    "published": 1741853400,
    "day_prices": {
      "2025-03-13T13:30:00+00:00": 59.9900016784668,
      "2025-03-13T14:30:00+00:00": 60.5,
      "2025-03-13T15:30:00+00:00": 60.630001068115234,
      "2025-03-13T16:30:00+00:00": 60.43000030517578,
      "2025-03-13T17:30:00+00:00": 60.224998474121094,
      "2025-03-13T18:30:00+00:00": 60.16999816894531,
      "2025-03-13T19:30:00+00:00": 60.23500061035156
    },
    "sentiment": 0.6996582746505737
  },
  {
    "title": "Bristol-Myers Squibb Company (BMY) Presents at Leerink Partners 2025 Global Healthcare Conference (Transcript)",
    "published": 1741801564,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 60.720001220703125,
      "2025-03-12T14:30:00+00:00": 60.04499816894531,
      "2025-03-12T15:30:00+00:00": 60.17499923706055,
      "2025-03-12T16:30:00+00:00": 60.33000183105469,
      "2025-03-12T17:30:00+00:00": 60.25,
      "2025-03-12T18:30:00+00:00": 60.162899017333984,
      "2025-03-12T19:30:00+00:00": 59.83000183105469
    },
    "sentiment": 0.9298655390739441
  },
  {
    "title": "Caterpillar: Diversification Without Diworsification; Home Depot Looks Healthy, So Do Others",
    "published": 1741786147,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 60.720001220703125,
      "2025-03-12T14:30:00+00:00": 60.04499816894531,
      "2025-03-12T15:30:00+00:00": 60.17499923706055,
      "2025-03-12T16:30:00+00:00": 60.33000183105469,
      "2025-03-12T17:30:00+00:00": 60.25,
      "2025-03-12T18:30:00+00:00": 60.162899017333984,
      "2025-03-12T19:30:00+00:00": 59.83000183105469
    },
    "sentiment": 0.8469449877738953
  },
  {
    "title": "Bristol-Myers Squibb To Acquire 2seventy bio - A Sad But Inevitable End To A Cell Therapy Pioneer",
    "published": 1741782139,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 60.720001220703125,
      "2025-03-12T14:30:00+00:00": 60.04499816894531,
      "2025-03-12T15:30:00+00:00": 60.17499923706055,
      "2025-03-12T16:30:00+00:00": 60.33000183105469,
      "2025-03-12T17:30:00+00:00": 60.25,
      "2025-03-12T18:30:00+00:00": 60.162899017333984,
      "2025-03-12T19:30:00+00:00": 59.83000183105469
    },
    "sentiment": 0.7562294006347656
  },
  {
    "title": "BMS to acquire longtime cell therapy partner 2seventy bio for $286m",
    "published": 1741730248,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 62.79999923706055,
      "2025-03-11T14:30:00+00:00": 61.935001373291016,
      "2025-03-11T15:30:00+00:00": 61.75,
      "2025-03-11T16:30:00+00:00": 61.69499969482422,
      "2025-03-11T17:30:00+00:00": 61.349998474121094,
      "2025-03-11T18:30:00+00:00": 61.59000015258789,
      "2025-03-11T19:30:00+00:00": 61.57500076293945
    },
    "sentiment": 0.8862149715423584
  },
  {
    "title": "Legend Biotech's Carvykti Is Taking Off, And It's Still Early (Rating Upgrade)",
    "published": 1741710774,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 62.79999923706055,
      "2025-03-11T14:30:00+00:00": 61.935001373291016,
      "2025-03-11T15:30:00+00:00": 61.75,
      "2025-03-11T16:30:00+00:00": 61.69499969482422,
      "2025-03-11T17:30:00+00:00": 61.349998474121094,
      "2025-03-11T18:30:00+00:00": 61.59000015258789,
      "2025-03-11T19:30:00+00:00": 61.57500076293945
    },
    "sentiment": 0.6662291884422302
  },
  {
    "title": "ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc.",
    "published": 1741707125,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 62.79999923706055,
      "2025-03-11T14:30:00+00:00": 61.935001373291016,
      "2025-03-11T15:30:00+00:00": 61.75,
      "2025-03-11T16:30:00+00:00": 61.69499969482422,
      "2025-03-11T17:30:00+00:00": 61.349998474121094,
      "2025-03-11T18:30:00+00:00": 61.59000015258789,
      "2025-03-11T19:30:00+00:00": 61.57500076293945
    },
    "sentiment": 0.8515198230743408
  },
  {
    "title": "2seventy bio, Bluebird\u2019s cell therapy spinout, sells to Bristol Myers for less than $300M",
    "published": 1741691100,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 62.79999923706055,
      "2025-03-11T14:30:00+00:00": 61.935001373291016,
      "2025-03-11T15:30:00+00:00": 61.75,
      "2025-03-11T16:30:00+00:00": 61.69499969482422,
      "2025-03-11T17:30:00+00:00": 61.349998474121094,
      "2025-03-11T18:30:00+00:00": 61.59000015258789,
      "2025-03-11T19:30:00+00:00": 61.57500076293945
    },
    "sentiment": 0.9487780928611755
  },
  {
    "title": "Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out",
    "published": 1741638646,
    "day_prices": {
      "2025-03-10T13:30:00+00:00": 60.95000076293945,
      "2025-03-10T14:30:00+00:00": 62.6150016784668,
      "2025-03-10T15:30:00+00:00": 62.619998931884766,
      "2025-03-10T16:30:00+00:00": 62.680198669433594,
      "2025-03-10T17:30:00+00:00": 62.75,
      "2025-03-10T18:30:00+00:00": 62.89649963378906,
      "2025-03-10T19:30:00+00:00": 62.849998474121094
    },
    "sentiment": 0.745956301689148
  },
  {
    "title": "Bristol-Myers Squibb Company (BMY): One of the Best Performing Dividend Stocks to Buy Now",
    "published": 1741617371,
    "day_prices": {
      "2025-03-10T13:30:00+00:00": 60.95000076293945,
      "2025-03-10T14:30:00+00:00": 62.6150016784668,
      "2025-03-10T15:30:00+00:00": 62.619998931884766,
      "2025-03-10T16:30:00+00:00": 62.680198669433594,
      "2025-03-10T17:30:00+00:00": 62.75,
      "2025-03-10T18:30:00+00:00": 62.89649963378906,
      "2025-03-10T19:30:00+00:00": 62.849998474121094
    },
    "sentiment": 0.8619315028190613
  },
  {
    "title": "Bristol Myers Squibb Presents Late-Breaking Data from Phase 3 POETYK PsA-2 Trial Demonstrating Superiority of Sotyktu Compared With Placebo in Adults with Psoriatic Arthritis",
    "published": 1741610291,
    "day_prices": {
      "2025-03-10T13:30:00+00:00": 60.95000076293945,
      "2025-03-10T14:30:00+00:00": 62.6150016784668,
      "2025-03-10T15:30:00+00:00": 62.619998931884766,
      "2025-03-10T16:30:00+00:00": 62.680198669433594,
      "2025-03-10T17:30:00+00:00": 62.75,
      "2025-03-10T18:30:00+00:00": 62.89649963378906,
      "2025-03-10T19:30:00+00:00": 62.849998474121094
    },
    "sentiment": 0.9304590821266174
  },
  {
    "title": "EC approves BMS\u2019 Opdivo and Yervoy combo for HCC",
    "published": 1741609959,
    "day_prices": {
      "2025-03-10T13:30:00+00:00": 60.95000076293945,
      "2025-03-10T14:30:00+00:00": 62.6150016784668,
      "2025-03-10T15:30:00+00:00": 62.619998931884766,
      "2025-03-10T16:30:00+00:00": 62.680198669433594,
      "2025-03-10T17:30:00+00:00": 62.75,
      "2025-03-10T18:30:00+00:00": 62.89649963378906,
      "2025-03-10T19:30:00+00:00": 62.849998474121094
    },
    "sentiment": 0.7954704165458679
  },
  {
    "title": "Is Bristol-Myers Squibb Company (BMY) The Best Cheap Dividend Stock To Buy Right Now?",
    "published": 1741461617,
    "day_prices": {},
    "sentiment": 0.9087998270988464
  },
  {
    "title": "I'm Locking 9-11% FCF Yields On These Dividend Icons",
    "published": 1741420800,
    "day_prices": {},
    "sentiment": 0.9008210897445679
  },
  {
    "title": "Pfizer Vs. Johnson & Johnson: Who's The Better Bargain For Investors",
    "published": 1741340054,
    "day_prices": {
      "2025-03-07T14:30:00+00:00": 60.45000076293945,
      "2025-03-07T15:30:00+00:00": 62.665000915527344,
      "2025-03-07T16:30:00+00:00": 62.13999938964844,
      "2025-03-07T17:30:00+00:00": 61.88999938964844,
      "2025-03-07T18:30:00+00:00": 61.599998474121094,
      "2025-03-07T19:30:00+00:00": 61.595001220703125,
      "2025-03-07T20:30:00+00:00": 61.41999816894531
    },
    "sentiment": 0.8937485814094543
  },
  {
    "title": "Bristol Myers Squibb Receives European Commission Approval for Opdivo\u00ae (nivolumab) plus Yervoy\u00ae (ipilimumab) for the First-Line Treatment of Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma",
    "published": 1741330803,
    "day_prices": {
      "2025-03-07T14:30:00+00:00": 60.45000076293945,
      "2025-03-07T15:30:00+00:00": 62.665000915527344,
      "2025-03-07T16:30:00+00:00": 62.13999938964844,
      "2025-03-07T17:30:00+00:00": 61.88999938964844,
      "2025-03-07T18:30:00+00:00": 61.599998474121094,
      "2025-03-07T19:30:00+00:00": 61.595001220703125,
      "2025-03-07T20:30:00+00:00": 61.41999816894531
    },
    "sentiment": 0.9377069473266602
  },
  {
    "title": "Johnson & Johnson: No More Tears, Just Gains In Intra-Cellular Acquisition",
    "published": 1741173872,
    "day_prices": {
      "2025-03-05T14:30:00+00:00": 59.43000030517578,
      "2025-03-05T15:30:00+00:00": 59.89500045776367,
      "2025-03-05T16:30:00+00:00": 59.619998931884766,
      "2025-03-05T17:30:00+00:00": 60.060001373291016,
      "2025-03-05T18:30:00+00:00": 59.83000183105469,
      "2025-03-05T19:30:00+00:00": 60.05500030517578,
      "2025-03-05T20:30:00+00:00": 59.97999954223633
    },
    "sentiment": 0.8795713186264038
  },
  {
    "title": "Bristol Myers Squibb Announces Dividend",
    "published": 1741018803,
    "day_prices": {
      "2025-03-03T14:30:00+00:00": 59.75,
      "2025-03-03T15:30:00+00:00": 59.369998931884766,
      "2025-03-03T16:30:00+00:00": 59.54999923706055,
      "2025-03-03T17:30:00+00:00": 59.599998474121094,
      "2025-03-03T18:30:00+00:00": 59.60499954223633,
      "2025-03-03T19:30:00+00:00": 59.595001220703125,
      "2025-03-03T20:30:00+00:00": 59.584999084472656
    },
    "sentiment": 0.9250937700271606
  }
]